NEWLINK GENETICS CORP 4
4 · NEWLINK GENETICS CORP · Filed Oct 28, 2014
Insider Transaction Report
Form 4
NEWLINK GENETICS CORP(NLNK)
LINK GORDON H JR
Chief Financial Officer
Transactions
- Sale
Common Stock
2014-10-24$40.39/sh−2,500$100,975→ 14,413 total - Exercise/Conversion
Common Stock
2014-10-24$2.10/sh+2,500$5,250→ 16,913 total - Exercise/Conversion
Stock Option (Right to Buy)
2014-10-24−2,500→ 53,739 totalExercise: $2.10Exp: 2018-08-05→ Common Stock (2,500 underlying)
Footnotes (3)
- [F1]Includes 3,800 shares delivered net settlement upon vesting of 5,700 restricted stock units ("RSUs") previously reported as holdings of the Reporting Person granted under the Issuer's 2009 Equity Incentive Plan (the "Plan"). The RSUs became immediately vested under the terms of the separation agreement entered into between the Company and the Reporting Person on September 30, 2014.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.80, inclusive. The reporting person undertakes to provide to the issuer, any security holder of issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote to this Form 4.
- [F3]1/4th of the shares vest on August 4, 2009, which is one year after the vesting commencement date. 1/48th of the shares vest monthly thereafter over the next three years.